| For: | Hasan S, Thai N, Uemura T, Kudithipudi V, Renz P, Abel S, Kirichenko AV. Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy. World J Gastrointest Surg 2017; 9(12): 256-263 [PMID: 29359031 DOI: 10.4240/wjgs.v9.i12.256] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i12/256.htm |
| Number | Citing Articles |
| 1 |
Chien Pong Chen. Role of Radiotherapy in the Treatment of Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology 2019; 7(X) doi: 10.14218/JCTH.2018.00060
|
| 2 |
Noriko Kishi, Naoyuki Kanayama, Takero Hirata, Shingo Ohira, Kentaro Wada, Yoshifumi Kawaguchi, Koji Konishi, Shigenori Nagata, Shin-ichi Nakatsuka, Shigeru Marubashi, Akira Tomokuni, Hiroshi Wada, Shogo Kobayashi, Yasuhiko Tomita, Teruki Teshima. Preoperative Stereotactic Body Radiotherapy to Portal Vein Tumour Thrombus in Hepatocellular Carcinoma: Clinical and Pathological Analysis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60871-0
|
| 3 |
Héloïse Giudicelli, Mickaël Andraud, Mathilde Wagner, Rémi Bourdais, Claire Goumard, Olivier Scatton, Dominique Thabut, Jean‐Marc Simon, Manon Allaire. Portal‐hypertension features are associated with ascites occurrence and survival in patients with hepatocellular carcinoma treated by external radiotherapy. United European Gastroenterology Journal 2023; 11(10) doi: 10.1002/ueg2.12488
|
| 4 |
Brett H. Diamond, Kara Banson, Jonathan Ayash, Peter Lee, Utkarsh C. Shukla, Gavin Jones, Paul Rava, Thomas J. Fitzgerald, Shirin Sioshansi. Outcomes After Stereotactic Body Radiation for Hepatocellular Carcinoma in Patients With Child-Pugh A Versus Child-Pugh B/C Cirrhosis. Advances in Radiation Oncology 2024; 9(12) doi: 10.1016/j.adro.2024.101631
|
| 5 |
Smith Apisarnthanarax, Aisling Barry, Minsong Cao, Brian Czito, Ronald DeMatteo, Mary Drinane, Christopher L. Hallemeier, Eugene J. Koay, Foster Lasley, Jeffrey Meyer, Dawn Owen, Jennifer Pursley, Stephanie K. Schaub, Grace Smith, Neeta K. Venepalli, Gazi Zibari, Higinia Cardenes. External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline. Practical Radiation Oncology 2022; 12(1) doi: 10.1016/j.prro.2021.09.004
|
| 6 |
Laila A. Gharzai, Chang Wang, Ming Tang, William C. Jackson, Christopher Maurino, Matthew M. Cousins, Mishal Mendiratta-Lala, Neehar D. Parikh, Charles S. Mayo, Randall K. Ten Haken, Dawn Owen, Kyle C. Cuneo, Matthew J. Schipper, Theodore S. Lawrence. Efficacy of a Second Course of Radiation for Patients With Metachronous Hepatocellular Carcinoma. Practical Radiation Oncology 2023; 13(6) doi: 10.1016/j.prro.2023.05.008
|
| 7 |
Mark P. Dumago, Ryan Anthony F. Agas, Carl Jay E. Jainar, Eugene T. Yap, Lester Bryan A. Co, Teresa T. Sy Ortin. Stereotactic Body Radiation Therapy With or Without Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone in Early-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Journal of Gastrointestinal Cancer 2023; 54(4) doi: 10.1007/s12029-023-00940-5
|
| 8 |
Shaakir Hasan, Paul Renz, Matthew Packard, Sean Horrigan, Steven Gresswell, Alexander V. Kirichenko. Effect of Daily and Every Other Day Stereotactic Body Radiation Therapy Schedules on Treatment-Related Fatigue in Patients With Hepatocellular Carcinoma. Practical Radiation Oncology 2019; 9(1) doi: 10.1016/j.prro.2018.06.005
|
| 9 |
Shaakir Hasan, Stephen Abel, Tadahiro Uemura, Vivek Verma, Eugene J. Koay, Joseph Herman, Ngoc Thai, Alexander Kirichenko. Liver transplant mortality and morbidity following preoperative radiotherapy for hepatocellular carcinoma. HPB 2020; 22(5) doi: 10.1016/j.hpb.2019.10.006
|
| 10 |
Jared R. Robbins, Ryan K. Schmid, Abdulrahman Y. Hammad, Thomas Clark Gamblin, Beth A. Erickson. Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival. Cancer Medicine 2019; 8(3) doi: 10.1002/cam4.1948
|
| 11 |
Zongyi Yin, Dongying Chen, Shuang Liang, Xiaowu Li. Neoadjuvant Therapy for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; doi: 10.2147/JHC.S357313
|
| 12 |
Katherine E. Poruk, Rupen Shah, Miral S. Grandhi, G. Paul Wright, Alexander A. Parikh. External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline—A Surgical Perspective. Annals of Surgical Oncology 2023; 30(8) doi: 10.1245/s10434-023-13586-1
|
| 13 |
Yunlong Sun, Bo Pang, Yingzhe Wang, Jinglei Xiao, Dacheng Jiang. Baohuoside I Inhibits the Proliferation of Hepatocellular Carcinoma Cells via Apoptosis Signaling and NF‐kB Pathway. Chemistry & Biodiversity 2021; 18(6) doi: 10.1002/cbdv.202100063
|
| 14 |
|
| 15 |
S. Hasan, Stephen Abel, Imraan Jan, Tadahiro Uemura, N. Thai, A. V. Kirichenko. The albumin-bilirubin (ALBI) model in hepatocellular carcinoma (HCC) may better predict hepatic failure in patients with traditionally low-risk cirrhosis following definitive stereotactic body radiotherapy (SBRT). Journal of Radiation Oncology 2018; 7(3) doi: 10.1007/s13566-018-0354-7
|
| 16 |
Zachary J. Brown, Diamantis I. Tsilimigras, Samantha M. Ruff, Alireza Mohseni, Ihab R. Kamel, Jordan M. Cloyd, Timothy M. Pawlik. Management of Hepatocellular Carcinoma. JAMA Surgery 2023; 158(4) doi: 10.1001/jamasurg.2022.7989
|
| 17 |
Christian Velten, Megi Gjini, Wolfgang A. Tomé, N. Patrik Brodin, Rafi Kabarriti. DCE-MRI functional NTCP modeling in SBRT for hepatocellular carcinoma. Physica Medica 2025; 133 doi: 10.1016/j.ejmp.2025.104958
|
| 18 |
Katsuhiko Tsutsumi, Kenta Yamamoto, Yumi Oie, Takayuki Miyachi, Yutaka Kato, Kentaro Yamao, Takuya Ishikawa, Yoji Ishizu, Takashi Honda, Hiroki Kawashima. Fiducial marker placement for hepatocellular carcinoma using magnetic resonance imaging–ultrasound fusion guidance: targeting accuracy and determinants of error (with video). Journal of Medical Ultrasonics 2026; doi: 10.1007/s10396-026-01624-w
|
| 19 |
|
| 20 |
Namita E. Mathew, Mohammad Elsayed, Nariman Nezami, Bill S. Majdalany, Ripal Gandhi, Michael Haber, Zachary L. Bercu, Nima Kokabi. Systematic Review of Radiation-Based Therapies for Hepatocellular Carcinoma. Digestive Disease Interventions 2021; 5(02) doi: 10.1055/s-0041-1728807
|
| 21 |
M. Dobrzycka, P. Spychalski, O. Rostkowska, M. Wilczyński, P. Kobiela, M. Grąt, V. Dell’Acqua, M. Høyer, B. A. Jereczek-Fossa. Stereotactic body radiation therapy for early-stage hepatocellular carcinoma – a systematic review on outcome. Acta Oncologica 2019; 58(12) doi: 10.1080/0284186X.2019.1657942
|
| 22 |
Mihir D. Shanker, Pereshin Moodaley, Wei Soon, Howard Y. Liu, Yoo Young Lee, David I. Pryor. Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis of local control, survival and toxicity outcomes. Journal of Medical Imaging and Radiation Oncology 2021; 65(7) doi: 10.1111/1754-9485.13309
|
| 23 |
Alexander Kirichenko, Tadahiro Uemura, Yun Liang, Shaakir Hasan, Steven Abel, Paul Renz, Parisa Shamsesfandabadi, Jennifer Carpenter, Yue Yin, Ngoc Thai. Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC) With Single Photon Emission Computed Tomography (SPECT) Functional Treatment Planning in Patients With Advanced Hepatic Cirrhosis. Advances in Radiation Oncology 2024; 9(2) doi: 10.1016/j.adro.2023.101367
|